The biotech firm reported reduced operating losses and an improved cash position following a successful placing. Progress in its Nuvec® platform development and new collaborations were highlighted, though it remains pre-revenue.
The biotech company has announced a collaboration with the University of Strathclyde's CMAC facility to advance the development of its Nuvec gene delivery platform.
The biotech company reports successful targeted delivery of RNA to lung cancer cells using its Nuvec® platform, strengthening the potential of its gene delivery system.
The biotech company will announce its interim results and hold an investor presentation later this month.
The biotech company will present on its Nuvec® gene delivery system at an upcoming investor event.
The biotech company has published a new article highlighting the potential of its Nuvec® gene delivery system for RNA therapeutics.
The biotech company is hosting an investor webinar to provide a strategic update on the development of its Nuvec® gene delivery system.
The biotech company has appointed a new non-executive director to its board, representing its largest shareholder.
The biotech company updates on the development of its Nuvec® gene delivery system, highlighting upcoming work to strengthen the commercial data package.
The biotech company is hosting an investor event to provide updates on its Nuvec® gene delivery system and pipeline.